Related references
Note: Only part of the references are listed.Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia—When do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
Alan Garber et al.
Endocrine Practice (2013)
Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study
Joshua Z. Willey et al.
AMERICAN HEART JOURNAL (2011)
Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose
Ralph A. y DeFronzo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
COLESEVELAM HYDROCHLORIDE TO TREAT HYPERCHOLESTEROLEMIA AND IMPROVE GLYCEMIA IN PREDIABETES: A RANDOMIZED, PROSPECTIVE STUDY
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2010)
Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes
Michael R. Jones et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Full Accounting of Diabetes and Pre-Diabetes in the US Population in 1988-1994 and 2005-2006
Catherine C. Cowie et al.
DIABETES CARE (2009)
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance
Julio Rosenstock et al.
DIABETES CARE (2008)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes
AH Xiang et al.
DIABETES (2006)
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
A Ramachandran et al.
DIABETOLOGIA (2006)
Lifetime risk for diabetes mellitus in the United States
KMV Narayan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
TA Buchanan et al.
DIABETES (2002)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
